Cardicomm Solutions, Inc. Press Releases

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, is pleased to announce that Dr. Robin Black has been added to the Company’s board of directors. In addition, the Company would like to provide an update on its audit of its financial statements for the year ended December 31, 2023. The Company confirms that Dr. Robin...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, is pleased to announce the appointment of Mr. Robert Caines as Chief Financial Officer ("CFO") of the Company. Effective January 8, 2024, Mr. Caines assumed the role of CFO, replacing Mr. Etienne Grima who served as interim CFO since August 3, 2023. Mr. Caines will also...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, confirms to its customers and stakeholders that following a recent cyber attack the Company has successfully restored its systems and resumed full-scale operations stronger than ever. On July 25, 2023, the Company announced a cyber attack took place which disrupted...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions a cyber security incident on the Company’s servers. The Company has launched a comprehensive investigation to fully ascertain the source and extent of any data breach and is working closely with KPMG-EGYDE, relevant authorities and third-party cybersecurity experts to...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced today that it will not file its annual financial statements for the financial year ended December 31, 2022 (the "Financial Statements") and its management's discussion and analysis relating to the Financial Statements (collectively, the "Required Filings")...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, announces that it has completed an issuance of shares for debt (see the Company's press release dated December 23, 2022 for the Company's initial announcement respecting the proposed shares for debt issuance) and confirms completing changes to...

--> TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, is pleased to announce that it has secured a two year term renewal on $130,000 in loans which had a maturity date of December 31, 2022. The Company has described the original loans ($600,000 in total) in the Company's press release dated...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, a global provider of consumer heart monitoring and electrocardiogram (("ECG") device and software solutions, confirms a technology integration agreement with Utah-based CareXM LLC. ("CareXM"), a provider of virtual care and patient engagement...

--> TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, announces that it has issued 125,000 stock options to Etienne Grima, the Company's CEO, in accordance with his employment agreement. The options are exercisable at $0.05 per Share for five years from the date of grant and vest immediately....

--> TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, announced that it has completed an issuance of shares for debt (see the Company's press release dated December 31, 2021 for the Company's initial announcement respecting the proposed shares for debt issuance). Under debt settlement...

--> TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, is pleased to announce that it has entered into a revolving line-of-credit loan agreement dated as of December 18, 2021, representing additional available funding as needed of up to $230,000. The terms of the loan require that any borrowed...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, announces that it has begun work on a medical multiple biosignal monitoring platform that will support remote patient monitoring ("RPM") and telemedicine needs, including the use of wearable devices such as patches and wrist worn devices....

--> TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, announces that it has issued 125,000 stock options to Etienne Grima, the Company's CEO, in accordance with his employment agreement. The options are exercisable at $0.05 per Share for five years from the date of grant and vest immediately....

--> TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, announced that it has completed its previously announced issuance of shares for debt (see the Company’s press releases dated April 27, 2021 and April 8, 2021 for further details). Under debt settlement agreements, the Company has...

--> TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, announced the proposed issuance of shares for debt and the issuance of stock options. Under debt settlement agreements, the Company will issue an aggregate of 2,947,394 common shares of the Company (“Shares”) to a director,...

--> TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, announced the proposed issuance of shares and the issuance of stock options. Under shares for debt agreements, the Company will issue an aggregate of 406,250 common shares of the Company (“Shares”) to directors of the Company at...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, has received approval on an expanded ISO 13485:2016 (“ISO”) certification in compliance with the Medical Device Single Audit Program (“MDSAP”) for Canada and the United States, to include pulse oximetry...

--> TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, is confirming the appointment of a new Chief Financial Officer and completion of a debt to equity settlement. On December 29, 2020 the Company announced that two of its four lenders had exercised their right to convert loans that had been...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, announced that at the request of two of four lenders, CardioComm will be issuing common shares of the Company (each, a “Share”) to settle $250,000 worth of debt. Pursuant to debt settlement agreements with the two converting lenders,...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, confirms plans to develop a multi-lead, wireless, ECG patch device for use in clinics, skilled nursing facilities, clinical trials as well as to support remote patient monitoring (“RPM”) and telehealth services and prescribed in-home...

--> TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, confirms that it has secured renewals on $500,000 in loans which had a maturity date of December 31, 2020. The maturing loans to the Company were described in the Company’s press release dated December 21, 2016, and were extended in...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, confirms the start of an out-of-office ECG monitoring program using the HeartCheck™ CardiBeat Handheld ECG monitor, the GEMS™ Mobile RPM Smartphone app and the SMART Monitoring ECG triaging service to support prescribed in-home...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, confirms the start of a pharmacy-based ECG monitoring service to screen for prolonged QT interval for the prevention of drug induced sudden cardiac death. Under the Company’s Allied Health Professional Partner Program, the...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, is pleased to confirm it has entered into a technology integration agreement with LiveCare Corp. ("LiveCare") and a Value-Added Reseller and Distribution Agreement with Alliance Tele-Med ("Alliance"), to provide integrated ECG monitoring through...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, provides an update respecting its reliance on the coordinated relief provided by securities regulators, which consists of a 45-day extension for certain periodic filings required on or before June 1, 2020, pursuant to Ontario Instrument 51-502...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm" or the "Company"), a leading global medical provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, announces that it is relying on the coordinated relief provided by securities regulators, which consists of a 45-day extension for certain periodic filings required on or before June 1, 2020, pursuant to Ontario Instrument 51-502 Temporary...